Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells

被引:8
作者
Conceicao, M. M.
Tonso, A.
Freitas, C. B.
Pereira, C. A.
机构
[1] Inst Butantan, Lab Immunol Viral, BR-05503900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Escola Politecn, Dept Engn Quim, Sao Paulo, Brazil
[3] Vallee SA, Montes Claros, MG, Brazil
关键词
MDBK cells; PI-3; virus; microcarriers;
D O I
10.1016/j.vaccine.2007.08.048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viral antigens can be obtained from infected mammalian cells cultivated on microcarriers. We have worked out parameters for the production of bovine parainfluenza 3 (PI-3) virus by Mandin-Darby Bovine Kidney (MDBK) cells cultivated on Cytodex 1 microcarriers (MCs) in spinners flasks and bioreactor using fetal bovine serum (FBS) supplemented Eagle minimal essential medium (Eagle-MEM). Medium renewal during the cell culture was shown to be crucial for optimal MCs loading (>90% MCs with confluent cell monolayers) and cell growth (2.5 x 10(6) cells/mL and a mu(x) (h-(1)) 0.05). Since cell cultures performed with lower amount of MCs (1 g/L), showed good performances in terms of cell loading, we designed batch experiments with a lower concentration of MCs in view of optimizing the cell growth and virus production. Studies of cell growth with lower concentrations of MCs (0.85 g/L) showed that an increase in the initial cell seeding (from 7 to 40 cells/MC) led to a different kinetic of initial cell growth but to comparable final cell concentrations ((8-10) x 10(5) cells/mL at 120 h) and cell loading (210-270 cells/MC). Upon infection with PI-3 virus, cultures showed a decrease in cell growth and MC loading directly related to the multiplicity of infection (moi) used for virus infection. Infected cultures showed also a higher consumption of glucose and production of lactate. The PI-3 virus and PI-3 antigen production among the cultures was not significantly different and attained values ranging from, respectively, 7-9 log(10) TCID50/mL and 1.5-2.2 OD. The kinetics of PI-3 virus production showed a sharp increase during the first 24 h and those of PI-3 antigen increased after 24 h. The differential kinetics of PI-3 virus and PI-3 antigen can be explained by the virus sensitivity to temperature. In view of establishing a protocol of virus production and based on the previous experiments, MDBK cell cultures performed under medium perfusion in a bioreactor of 1.2 L were infected and the PI-3 virus production in 12 L attained 12 log(10) TCID50. Other than establishing a protocol for PI-3 production in MDBK cell cultures on Cytodex 1, the experiments are proposed as a basis for approaching the development of a virus production protocol in mammalian cells cultivated on microcarriers in bioreactors. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7785 / 7795
页数:11
相关论文
共 37 条
  • [1] Berry JM, 1999, BIOTECHNOL BIOENG, V62, P12, DOI 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO
  • [2] 2-G
  • [3] Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor
    Bleckwenn, NA
    Golding, H
    Bentley, WE
    Shiloach, J
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2005, 90 (06) : 663 - 674
  • [4] Bryson D. G., 1990, Virus infections of ruminants., P319
  • [5] COELINGH KLV, 1988, J INFECT DIS, V15, P655
  • [6] FRANK GH, 1970, AM J VET RES, V31, P1085
  • [7] Freshney R. I., 2010, Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications
  • [8] Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture
    Genzel, Y
    Fischer, M
    Reichl, U
    [J]. VACCINE, 2006, 24 (16) : 3261 - 3272
  • [9] Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine
    Ghendon, YZ
    Markushin, SG
    Akopova, II
    Koptiaeva, IB
    Nechaeva, EA
    Mazurkova, LA
    Radaeva, IF
    Kolokoltseva, TD
    [J]. VACCINE, 2005, 23 (38) : 4678 - 4684
  • [10] Detection of bovine viral diarrhea virus (BVDV) in seropositive cattle
    Gogorza, LM
    Morán, PE
    Larghi, JL
    Seguí, R
    Lissarrague, C
    Saracco, M
    Braun, M
    Esteban, EN
    [J]. PREVENTIVE VETERINARY MEDICINE, 2005, 72 (1-2) : 49 - 54